Breast conserving surgery (BCT): Every millimetre counts

Slides:



Advertisements
Similar presentations
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
Advertisements

DCIS – Are we cutting it? Dr Alex Lemaigre With thanks to:
Breast Cancer in Pregnancy
Screening Mammography: Regret or no regret? Joint Hospital Surgical Grand Round 19 May 2007 Yvonne Tsang Prince of Wales Hospital.
Breast Conservative Surgery: An Update How far should we go?
Joint Hospital Surgical Grand Round Accelerated partial breast irradiation: where should we go? Dr Ma Kwok Kuen Queen Mary Hospital.
Role of MRI in Breast Cancer Angela Kong Princess Margaret Hospital.
Hon-chi Yip Department of Surgery North District Hospital.
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Clinical Relevance of HER2 Overexpression/Amplification in Patients with Small Tumor Size and Node-Negative Breast Cancer Curigliano G et al. J Clin Oncol.
Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.
Radiotherapy in Carcinoma of the Breast Patrick S Swift, MD Director, Radiation Oncology Alta Bates Comprehensive Cancer Center Berkeley, CA.
Margins: less is just as good
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Neoadjuvant Chemotherapy for Ca Breast CY Choi UCH.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
Dilemma in management of DCIS
Wildiers H, et al. Lancet Oncol. 2007;8:1101. Breast Cancer in Elderly (>65 Years) Recommendations of the International Society of Geriatric Oncology Surgical.
Ductal Carcinoma In Situ (DCIS)
Management of DCIS KWH Experience Dr. Carmen Ho.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
18th Annual Perspectives in Breast Cancer
Targeted Intraoperative Radiotherapy versus Whole Breast Radiotherapy for Breast Cancer (TARGIT-A Trial): An International, Prospective, Randomised, Non-Inferiority.
Quantifying the Morbidity of the Unplanned Sarcoma Excision
Thyroid Debate (Papillary Thyroid Cancer: Extent of Thyroidectomy) 30 Aug 2007 Surgery-OMMC JGGuerra, MD HCruz, MD.
DL Wickerham MD Deputy Chairman NRG Oncology Oct 5, 2015
The Use of Pathologic Factors to Assist in Establishing Adequacy of Excision Prior to Radiation Therapy in Patients Treated with Breast Conserving Therapy.
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
The impact of age on outcome in early-stage breast cancer 방사선종양학과 R2. 최진현.
Nicolas Ajkay, MD, FACS Assistant Professor of Surgery
Radiation after Neoadjuvant Systemic Therapy: Are the Rules Different?
Indications for Breast MR Imaging
Prognostic significance of tumor subtypes in male breast cancer:
R. Michelle Sarin, MD Mentor: Jeffrey Fowler, MD
Operative Approach and
Copyright © 2013 American Medical Association. All rights reserved.
Mammograms and Breast Exams: When to start /stop mammograms
Dr Amit Gupta Associate Professor Dept Of Surgery
Corresponding Author ( ):
Surgical Management of the Breast in Breast Cancer
The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy  C.
Basile Pache, Antonia Digklia*, Nicolas Demartines, Maurice Matter.
Compassionate People World Class Care
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
THBT neoadjuvant endocrine therapy is to be used in post-menopausal breast cancer woman Antonino Grassadonia Università «G. D’Annunzio» – Chieti-Pescara.
Marcelo Calil Instituto Brasileiro de Controle do Câncer
Definition of Cancer Screening
Figure 1 Overall survival and cause-specific survival after breast conservation treatment with radiation for 1003 patients with mammographically detected.
But how to treat those with positive SLNB? Results and Discussion
SPECIMEN SONOGRAM - Procedure
Breast Screening and Risk Assessment
1st UK Interdisciplinary Breast Cancer Symposium
Peter T. Simpson, Leonard M. Da Silva, Sunil R. Lakhani  Cancer Cell 
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Intellectual property of the EBCTCG trialists.
Mastectomy and Reconstruction In Asian Breast Cancer Patients
Dr T P E Wells 13 July 2018 Breast SSG Bath
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Published online September 20, 2017 by JAMA Surgery
Continuing Adjuvant Tamoxifen to 10 Years
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Diagnosis of breast cancer in women age 40 and younger: Delays in diagnosis result from underuse of genetic testing and breast imaging 95% of patients.
Prognosis of angiosarcoma at different anatomic sites
Presentation transcript:

Breast conserving surgery (BCT): Every millimetre counts Joint hospital surgical grand round 15/10/2016

Outline Background Surgical options Adequacy of margin Invasive Ductal Carcinoma (IDC) Ductal Carcinoma In Situ (DCIS)

Breast Cancer Background Most common female cancer Mean age of diagnosis 51.2 11.7% in situ cancers 93.8% ductal type Hong Kong cancer fund statistics Hong Kong Breast Cancer Registry report No. 7 issue 2015 14,400 patients

Surgical options Mastectomy Wide local excision + radiotherapy (BCT)

BCT: Adequacy of margin Invasive ductal carcinoma No ink on tumour At least 2-fold increase risk in positive margins Wider margin widths do not significantly lower risk of ipsilateral breast tumour recurrence (IBTR) Not nullified by histological type, systemic therapy, mode of irradiation Moran MS, Schnitt SJ, Giuliano AE, et al. (2014) Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 32:1507–1515

BCT: Adequacy of margin Ductal carcinoma in situ (DCIS) BCT + whole-breast radiation therapy (WBRT) reduces rate of IBTR 10-year absolute risk reduction 15.2 %1 Non-significant difference in cancer-specific mortality2 1. Correa C, McGale P, Taylor C, et al. (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162–177 2. Narod SA, Iqbal J, Giannakeas V. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2015 doi: 10.1001/jamaoncol.2015.2510

BCT: Adequacy of margin Ductal carcinoma in situ (DCIS) No consensus on what constitutes adequate margin Re-excision: Complications Discomfort Cosmetics Costs

Pubmed Ductal carcinoma in situ, Breast conserving surgery, Margin Systemic review / meta-analysis 14 results Different conclusions Threshold of 2mm as good as a wider margin1 Margin as wide as possible (greater than 10 mm)2 1. Dunne C, Burke JP, Morrow M. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009 Apr 2. Wang SY, Chu H, Shamliyan T et el. Network Meta-analysis of Margin Threshold for Women With Ductal Carcinoma In Situ. J Natl Cancer Inst. 2012 Apr

Screen cap pubmed

Consensus guideline 2016 Journal of clinical oncology, 2016 Meta-analysis 20 retrospective studies 7883 DCIS patients 865 IBTR Median follow-up 78.3 months 50 patients with DCIS treated with local excision >4 years follow-up

Guideline recommendations A positive margin, defined as ink on DCIS, is associated with a significant increase in IBTR. This increased risk is not nullified by the use of WBRT. 10-year IBTR rate 24% vs 12% 50% invasive recurrences

Guideline recommendations Margins of at least 2 mm are associated with a reduced risk of IBTR relative to narrower margin widths in patients receiving WBRT. The routine practice of obtaining negative margin widths wider than 2 mm is not supported by the evidence. Statistically significant decrease IBTR for 2mm compared with 0 or 1mm (OR 0.51, P=0.01) No significant differences in IBRT between 2mm, 3 or 5mm and 10mm margins threshold (P>0.40) Marinovich ML, Azizi L, Macaskill P, et al. (in press) The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: A meta-analysis. Ann Surg Oncol

2mm Margin width Multi-focal DCIS, with gaps of uninvolved tissue between foci Margin assessment limitations Sampling, ex-vivo specimen, ink tracking Selective re-excision for margins <2mm Factors: (residual calcifications on postexcision mammography, extent of DCIS in proximity to margin, which margin is close [i.e., anterior excised to skin or posterior excised to pectoral fascia v margins associated with residual breast tissue]), cosmetic impact of re-excision, and overall life expectancy

Guideline recommendations Excision without WBRT associated with higher rates of IBTR (26.0% vs 12.0%, P < 0.00001) Inconclusive evidence to suggest lower rate with wider margin than 2mm Van Zee et al (2015): 16% for >10 mm, 23% for between 2.1 and 10 mm 27% for > 0-2 mm 41% for positive margins Other studies: no significant difference Van Zee et al: 16%for margins >10 mm, and increased to 23% for margins between 2.1 and 10 mm, 27% for > 0-2 mm, and 41% for positive margins Other studies (ECOG): no significant difference

Guideline recommendations Endocrine therapy reduced rate of IBTR in patient with positive margin (17.4% vs 11.5%) No evidence to suggest association with margin width Insufficient data to address association of margin width with Patient factors Radiation delivery DCIS with microinvasion

Conclusion Current evidence support adequate margin of 2mm for DCIS undergone BCT with WBRT Selective re-excision for margins <2mm